Population Research Committee

The Population Research Committee (PRC), and its expert review panels in Early Diagnosis, Prevention and Epidemiology, are responsible for the oversight, development, review, funding and management of a portfolio of awards for research Programmes, Project Grants and Fellowships in population science.​

Research areas

Early Diagnosis

  • Cancer symptoms: natural history and awareness
  • The early diagnosis pathway including alternative routes to diagnosis
  • Interventions to increase presentation to primary care or uptake of screening
  • Screening as a form of early diagnosis

Prevention

  • Behavioural and lifestyle  interventions to prevent cancer (individual or population level), including prevention of cancer recurrence
  • Adherence to chemoprevention
  • Screening as a form of prevention

Epidemiology

  • Classical and health epidemiology, plus survival and incidence rates
  • Repurposing of existing cohorts for ‘omics studies (excluding genetic epidemiology)
  • Secondary physical effects of cancer treatment
  • Methodological and statistical research relating to population sciences

How proposals are judged

Applications are judged on the basis of scientific excellence, innovation and relevance to cancer research. The Committee and its expert review panels meet twice a year and assess all applications on the basis of their scientific and strategic importance, whilst also studying the expert peer review which is collated for each grant.

 

Chair of the Population Research Committee

Professor Per Hall – Karolinska Institute

Vice-chair of the Population Research Committee

Professor Deborah Ashby – Imperial College London

Membership of the Population Research Committee

Professor Linda Bauld – University of Stirling

Dr Mark Beresford – Royal United Hospital Bath

Professor Zhengming Chen – University of Oxford

Dr Diane Dixon – University of Strathclyde

Professor Mark Gilthorpe – University of Leeds

Professor Peter Harris – University of Sussex

Dr Rolando Herrero – International Agency for Research on Cancer (IARC)

Professor Richard Martin – University of Bristol

Dr Peter Murchie – University of Aberdeen

Professor Liam Murray – Queen's University Belfast

Mr Peter Rainey – Consumer Representative

Professor Peter Sasieni – Queen Mary, University of London

Professor Xifeng Wu – MD Anderson Cancer Center

Chair of the Early Diagnosis Panel

Professor David Weller – University of Edinburgh

Vice-chair of the Early Diagnosis Panel

TBC

Membership of the Early Diagnosis Panel

Professor Paul Aylin – Imperial College London

Dr Stephan Dahl – University of Hull

Professor Jill Francis – City University

Mr Tom Haswell – Consumer Representative

Professor Greg Rubin – University of Durham

Professor Peter Vedsted – Aarhus University

Dr Katriina Whitaker – University of Surrey

Chair of the Prevention Panel

Dr Diane Dixon – University of Strathclyde

Vice-chair of the Prevention Panel

Professor Peter Harris – University of Sussex

Membership of the Prevention Panel

Dr Jean Adams – University of Cambridge

Professor Linda Bauld – University of Stirling

Professor Marijn de Bruin – University of Aberdeen

Professor Hilary Graham – University of York

Professor Anne Rogers – University of Southampton

Professor Sally Wyke – University of Glasgow

Chair of the Epidemiology Panel

Professor Richard Martin – University of Bristol

Vice-chair of the Epidemiology Panel

Professor Mark Gilthorpe – University of Leeds

Membership of the Epidemiology Panel

Dr Marie Cantwell – Queen’s University Belfast

Dr Tim Card – University of Nottingham

Professor Zhengming Chen – University of Oxford

Professor Paul Lambert – University of Leicester

Professor Jill Pell – University of Southampton

Chair of the Fellowships Interview Panel

Dr Peter Murchie – University of Aberdeen

Contact for this committee

Dr Anne Helme

Anne.Helme@cancer.org.uk

Tel: +44 (0) 20 3469 5442

Post doc in epidemiology, Michael O’Rorke

Michael was awarded a Postdoctoral Fellowship in 2014 from our Population Research Committee, to work on a project exploring the association of beta adrenergic receptor expression and beta-blocker use with breast cancer survival.

Read more

Share this page